India isn’t the only one hiring, others are hiring too! Check it out! (Isn’t it tempting?)
Faced with fast growth of its domestic pharmaceutical industry and increasing quality-control problems at some of its biggest drugmakers, Indian authorities plan to add 110 inspectors – a 65 percent boost above current levels – over the next six months as part of a plan to invest some $3 billion in order to boost oversight, according to InPharma Technologist. Hundreds more inspectors are expected to be hired later. The planned initiative comes amid sweeping changes planned for licensing manufacturing facilities and a growing number of scandals. In recent weeks, the US FDA issued an import ban on products made from yet another Ranbaxy Laboratories plant and issued scathing warning letters to other drugmakers, Wockhardt and Agila Specialties, a unit of Strides Arcolab that is being purchased by Mylan Laboratories.
Don’t forget, hundreds of biopharma companies are hiring! (We know you can’t resist.)
